As most patients with type 2 diabetes are treated in the primary-care setting, the increasing utilization of SGLT2 inhibitors and GLP1 agonists by our primary-care colleagues will improve outcomes in people with type 2 diabetes on a population level. The clinical guidelines cautioned against treating people with type 2 diabetes with inadequate glycemic control with dipeptidyl peptidase-4 (DPP-4) inhibitors, saying that high-certainty evidence showed that adding a DPP-4 inhibitor does not reduce morbidity or all-cause mortality.
As the active ingredient behind Ozempic and Wegovy loses exclusivity, we are witnessing a fundamental shift in how metabolic health is treated globally
But compounded with dehydration from vomiting, reduced food intake from extreme appetite suppression, and interaction with other diabetes medications, blood sugar can drop to dangerous levels
3 Glucose is a requisite metabolic fuel for brain cells
Ro Body Ro built its reputation as a broad telehealth platform covering everything from hair loss to erectile dysfunction before expanding heavily into GLP-1 weight loss care through its Body program
As GLP-1 medications become more widely used for metabolic health and weight management, interest in needle-free alternatives has surged
